Core Medical Publishing
Home About Us Products & Services
Frequently Asked Questions Contact Us Privacy Policy
Publishing
Core Evidence
Editorial
Aims and Scope
Features and Benefits
Online Early
Current Issue
Previous Issues
Future Issues
Free Trial
openaccess
Permissions and Reprints
Editorial Information
Call For Papers
Continuing Medical Education
New CME Activities
MedicVision
MedicVision
Online Early
Online Early
Current Issue
Current Issue
Core Evidence
Vol. 2, No. 4
July, 2008
ISSN: 1555-1741
Free Trial
Free Trial
Sample Sample
Call For Papers

Core Evidence

Opportunity to publish in an international, peer-reviewed, indexed journal.

If you are involved in making prescribing decisions or drug choices in the clinical, formulary, or policy setting, have you considered getting your work published?

Core Evidence is the first peer-reviewed journal to evaluate the outcomes evidence central to rational drug selection and effective clinical decisions. Launched in July 2005, the journal meets the need for published, independent, evidence-based reviews of new drugs. We are now expanding the scope of the journal and inviting submissions of original research and reviews.

Core Evidence welcomes contributions of the following:
Drug evaluations
Drug class reviews
Formulary monographs
Technology appraisals
Cost impact and resource utilisation studies
Drug utilisation reviews
Impact of new drugs on therapeutic guidelines
Outcomes and effectiveness studies
Medicines management studies

Key facts about Core Evidence:

Audience: Core Evidence reaches an international audience of medicines information professionals, formulary decision makers, prescribing advisers and pharmacists, practicing physicians, healthcare administrators and commissioners
Indexing: Core Evidence is abstracted and indexed in EMBASE, Scopus, CINAHL, and HEED, and syndicated on Medscape.com. Indexing in other major databases (e.g. Medline) is being applied for
Peer review: Core Evidence is peer reviewed by an internationally recognised honorary editorial board and review panel
Print and online: Core Evidence is available in print, and online at www.ingenta.com
Open access: to ensure rapid free availability online, Core Evidence offers an open access option to authors
Share your work and communicate with your peers and colleagues around the world. Contact editor@coreevidence.com or call +44 1565 752114 for more details.